Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

BLOOD

Baliakas, P; Agathangelidis, A; Hadzidimitriou, A; Sutton, LA; Minga, E; Tsanousa, A; Scarfo, L; Davis, Z; Yan, XJ; Shanafelt, T; Plevova, K; Sandberg, Y; Vojdeman, FJ; Boudjogra, M; Tzenou, T; Chatzouli, M; Chu, CC; Veronese, S; Gardiner, A; Mansouri, L; Smedby, KE; Pedersen, LB; Moreno, D; Van Lom, K; Giudicelli, V; Francova, HS; Nguyen-Khac, F; Panagiotidis, P; Juliusson, G; Angelis, L; Anagnostopoulos, A; Lefranc, MP; Facco, M; Trentin, L; Catherwood, M; Montillo, M; Geisler, CH; Langerak, AW; Pospisilova, S; Chiorazzi, N; Oscier, D; Jelinek, DF; Darzentas, N; Belessi, C; Davi, F; Ghia, P; Rosenquist, R; Stamatopoulos, K, 2015: Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations. BLOOD 125(5), p. 856 - 859, doi: 10.1182/blood-2014-09-600874

Research Groups:

CEITEC authors: